State Street Corporation 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 11:13 am Sale |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
STATE STREET CORP STT |
2,502,946 3.600% |
-2,619,949 (-51.14%) |
Filing |
| 2024-01-25 09:36 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
STATE STREET CORP STT |
5,122,895 9.200% |
2,621,926 (+104.84%) |
Filing |
| 2023-02-03 2:06 pm Purchase |
2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
STATE STREET CORP STT |
2,500,969 5.350% |
2,500,969 (New Position) |
Filing |